Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Hankuo Biology is a China-based manufacturer of chemical products, pharmaceutical intermediates, and anti-infective active ingredients. Publicly available business-scope listings indicate the company produces compounds including florfenicol, thiamphenicol, meropenem-related intermediates, tartaric-acid derivatives, and other fine chemicals used in pharmaceutical and industrial applications. The company appears to operate as a commercial manufacturing business rather than a therapeutic drug developer, with product catalog exposure through chemical supplier marketplaces and Chinese business registries. Based on available evidence, it is active and involved in health-related supply through pharmaceutical chemical manufacturing, but there is no clear public evidence of a proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Hankuo Biology.